CAN FITE BIOPHARMA : Fite Announces Late-Breaking Abstract Presentation on Namodenoson Phase II Results at the Ameri Association of Clinical Oncology Annual Meeting

Press/Media

Period11 Apr 2019

Media coverage

1

Media coverage